Selected research
Market Outlook & Growth Opportunities
Global Poultry Vaccines Market Outlook and Growth Opportunities 2026
Market perspective
The global Poultry Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Poultry Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Poultry Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Poultry Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Poultry Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Poultry Vaccines market include Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike and Phibro Animal Health Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Poultry Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Poultry Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Poultry Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Poultry Vaccines market.
Poultry Vaccines Segment by Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Poultry Vaccines Segment by Type
Live
Attenuated
Killed
Poultry Vaccines Segment by Application
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
Poultry Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Poultry Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Poultry Vaccines key companies, revenue, market share, and recent developments.
3. To split the Poultry Vaccines breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Poultry Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Poultry Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Poultry Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poultry Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poultry Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poultry Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Poultry Vaccines industry.
Chapter 3: Detailed analysis of Poultry Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Poultry Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Poultry Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Live
- Attenuated
- Killed
Applications
- NDV
- Marek ' s Disease
- IBD
- Infectious Bronchitis
- Influenza
- Others
Companies covered
- Merck
- Boehringer Ingelheim
- Ceva
- Zoetis
- Vaxxinova®
- Elanco
- QYH Biotech Co., Ltd
- Pulike
- Phibro Animal Health Corporation
- JinYu Biotechnology
- Harbin Pharmaceutical Group
- MEVAC
- Venky's
- Japfa Comfeed Indonesia
- Nisseiken
- Hile
- Hester Biosciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Poultry Vaccines Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Poultry Vaccines Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Poultry Vaccines Market Dynamics
- 2.1 Poultry Vaccines Industry Trends
- 2.2 Poultry Vaccines Industry Drivers
- 2.3 Poultry Vaccines Industry Opportunities and Challenges
- 2.4 Poultry Vaccines Industry Restraints
3 Poultry Vaccines Market by Company
- 3.1 Global Poultry Vaccines Company Revenue Ranking in 2025
- 3.2 Global Poultry Vaccines Revenue by Company (2021-2026)
- 3.3 Global Poultry Vaccines Company Ranking (2024-2026)
- 3.4 Global Poultry Vaccines Company Manufacturing Base and Headquarters
- 3.5 Global Poultry Vaccines Company Product Type and Application
- 3.6 Global Poultry Vaccines Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Poultry Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Poultry Vaccines Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Poultry Vaccines Market by Type
- 4.1 Poultry Vaccines Type Introduction
- 4.1.1 Live
- 4.1.2 Attenuated
- 4.1.3 Killed
- 4.2 Global Poultry Vaccines Sales Value by Type
- 4.2.1 Global Poultry Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Poultry Vaccines Sales Value by Type (2021-2032)
- 4.2.3 Global Poultry Vaccines Sales Value Share by Type (2021-2032)
5 Poultry Vaccines Market by Application
- 5.1 Poultry Vaccines Application Introduction
- 5.1.1 NDV
- 5.1.2 Marek ' s Disease
- 5.1.3 IBD
- 5.1.4 Infectious Bronchitis
- 5.1.5 Influenza
- 5.1.6 Others
- 5.2 Global Poultry Vaccines Sales Value by Application
- 5.2.1 Global Poultry Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Poultry Vaccines Sales Value by Application (2021-2032)
- 5.2.3 Global Poultry Vaccines Sales Value Share by Application (2021-2032)
6 Poultry Vaccines Regional Value Analysis
- 6.1 Global Poultry Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Poultry Vaccines Sales Value by Region (2021-2032)
- 6.2.1 Global Poultry Vaccines Sales Value by Region: 2021-2026
- 6.2.2 Global Poultry Vaccines Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Poultry Vaccines Sales Value (2021-2032)
- 6.3.2 North America Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Poultry Vaccines Sales Value (2021-2032)
- 6.4.2 Europe Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Poultry Vaccines Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Poultry Vaccines Sales Value (2021-2032)
- 6.6.2 South America Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Poultry Vaccines Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
7 Poultry Vaccines Country-level Value Analysis
- 7.1 Global Poultry Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Poultry Vaccines Sales Value by Country (2021-2032)
- 7.2.1 Global Poultry Vaccines Sales Value by Country (2021-2026)
- 7.2.2 Global Poultry Vaccines Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.7.2 France Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.14.2 China Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.17.2 India Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Poultry Vaccines Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Poultry Vaccines Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Poultry Vaccines Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Ceva
- 8.3.1 Ceva Company Information
- 8.3.2 Ceva Business Overview
- 8.3.3 Ceva Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.3.4 Ceva Poultry Vaccines Product Portfolio
- 8.3.5 Ceva Recent Developments
- 8.4 Zoetis
- 8.4.1 Zoetis Company Information
- 8.4.2 Zoetis Business Overview
- 8.4.3 Zoetis Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.4.4 Zoetis Poultry Vaccines Product Portfolio
- 8.4.5 Zoetis Recent Developments
- 8.5 Vaxxinova®
- 8.5.1 Vaxxinova® Company Information
- 8.5.2 Vaxxinova® Business Overview
- 8.5.3 Vaxxinova® Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.5.4 Vaxxinova® Poultry Vaccines Product Portfolio
- 8.5.5 Vaxxinova® Recent Developments
- 8.6 Elanco
- 8.6.1 Elanco Company Information
- 8.6.2 Elanco Business Overview
- 8.6.3 Elanco Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.6.4 Elanco Poultry Vaccines Product Portfolio
- 8.6.5 Elanco Recent Developments
- 8.7 QYH Biotech Co., Ltd
- 8.7.1 QYH Biotech Co., Ltd Company Information
- 8.7.2 QYH Biotech Co., Ltd Business Overview
- 8.7.3 QYH Biotech Co., Ltd Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.7.4 QYH Biotech Co., Ltd Poultry Vaccines Product Portfolio
- 8.7.5 QYH Biotech Co., Ltd Recent Developments
- 8.8 Pulike
- 8.8.1 Pulike Company Information
- 8.8.2 Pulike Business Overview
- 8.8.3 Pulike Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.8.4 Pulike Poultry Vaccines Product Portfolio
- 8.8.5 Pulike Recent Developments
- 8.9 Phibro Animal Health Corporation
- 8.9.1 Phibro Animal Health Corporation Company Information
- 8.9.2 Phibro Animal Health Corporation Business Overview
- 8.9.3 Phibro Animal Health Corporation Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.9.4 Phibro Animal Health Corporation Poultry Vaccines Product Portfolio
- 8.9.5 Phibro Animal Health Corporation Recent Developments
- 8.10 JinYu Biotechnology
- 8.10.1 JinYu Biotechnology Company Information
- 8.10.2 JinYu Biotechnology Business Overview
- 8.10.3 JinYu Biotechnology Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.10.4 JinYu Biotechnology Poultry Vaccines Product Portfolio
- 8.10.5 JinYu Biotechnology Recent Developments
- 8.11 Harbin Pharmaceutical Group
- 8.11.1 Harbin Pharmaceutical Group Company Information
- 8.11.2 Harbin Pharmaceutical Group Business Overview
- 8.11.3 Harbin Pharmaceutical Group Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.11.4 Harbin Pharmaceutical Group Poultry Vaccines Product Portfolio
- 8.11.5 Harbin Pharmaceutical Group Recent Developments
- 8.12 MEVAC
- 8.12.1 MEVAC Company Information
- 8.12.2 MEVAC Business Overview
- 8.12.3 MEVAC Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.12.4 MEVAC Poultry Vaccines Product Portfolio
- 8.12.5 MEVAC Recent Developments
- 8.13 Venky's
- 8.13.1 Venky's Company Information
- 8.13.2 Venky's Business Overview
- 8.13.3 Venky's Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.13.4 Venky's Poultry Vaccines Product Portfolio
- 8.13.5 Venky's Recent Developments
- 8.14 Japfa Comfeed Indonesia
- 8.14.1 Japfa Comfeed Indonesia Company Information
- 8.14.2 Japfa Comfeed Indonesia Business Overview
- 8.14.3 Japfa Comfeed Indonesia Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.14.4 Japfa Comfeed Indonesia Poultry Vaccines Product Portfolio
- 8.14.5 Japfa Comfeed Indonesia Recent Developments
- 8.15 Nisseiken
- 8.15.1 Nisseiken Company Information
- 8.15.2 Nisseiken Business Overview
- 8.15.3 Nisseiken Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.15.4 Nisseiken Poultry Vaccines Product Portfolio
- 8.15.5 Nisseiken Recent Developments
- 8.16 Hile
- 8.16.1 Hile Company Information
- 8.16.2 Hile Business Overview
- 8.16.3 Hile Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.16.4 Hile Poultry Vaccines Product Portfolio
- 8.16.5 Hile Recent Developments
- 8.17 Hester Biosciences
- 8.17.1 Hester Biosciences Company Information
- 8.17.2 Hester Biosciences Business Overview
- 8.17.3 Hester Biosciences Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 8.17.4 Hester Biosciences Poultry Vaccines Product Portfolio
- 8.17.5 Hester Biosciences Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst